Therapies / Medicine / Drugs / Drug / Biotech / BioTech / BioTechnology / Boston blog main / National blog main / National top stories / San Francisco / San Francisco blog main / San Francisco top stories / Seattle blog main / Alnylam / Alta Partners / Altitude Life Science Ventures / ARCH Venture Partners / Bill & Melinda Gates Foundation / Biogen / clinical trials / deals / Fred Hutchinson Cancer Research Center / George Scangos / Humabs Biomed / Infectious Disease / investing / Life Sciences / Oregon Health and Science University / Stanford University / startups / Vir Biotechnology / Visterra

Vir Biotech Vies for Global Approach to Tackling Infectious Disease

Posted on: Oct 18, 2017   |   Posted by: Biotech Mag Top

Vir Biotech Vies for Global Approach to Tackling Infectious Disease

Vir Biotechnology CEO George Scangos aims to develop new infectious disease drugs that can treat people in the U.S. and other developed countries. But he also wants to make...

Continue reading ...